SCHEMBL19785374

SCHEMBL19785374

CC(C)(C)c1cccc(-c2cccc(C(C)(C)C)c2Cl)c1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.48
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NOTUM Q6P988 2/20 0.37
KIF11 P52732 1/20 0.35
P2RX7 Q99572 2/20 0.34
ALOX12 P18054 1/20 0.34
PTPN5 P54829 1/20 0.32
TRPA1 O75762 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
PDCD1LG2 Q9BQ51 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24107301 0.89 CA2 (0.40) CA2GABRA1GABRB2ALDH1A1TSHR
SCHEMBL2199206 0.87 CA2 (0.55) CA2GABRA1GABRB2ALDH1A1TSHR
SCHEMBL30978766 0.85 CYP2A6 (0.45) CA2GABRA1GABRB2ALDH1A1TSHR
SCHEMBL17031795 0.84 CA2 (0.36) CA2GABRA1GABRB2ALDH1A1TSHR
SCHEMBL29265219 0.83 CYP2A6 (0.43) CA2GABRA1GABRB2ALDH1A1TSHR
SCHEMBL30703844 0.83 ALDH1A1 (0.46) CA2GABRA1GABRB2ALDH1A1TSHR
SCHEMBL9257718 0.81 P2RX7 (0.41) CA2GABRA1GABRB2ALDH1A1TSHR
SCHEMBL78891 0.80 CA2 (0.48) CA2GABRA1GABRB2ALDH1A1TSHR
SCHEMBL24107260 0.79 KIF11 (0.46) CA2ALDH1A1KIF11PTPN5TRPA1
SCHEMBL9626847 0.78 GABRA1 (0.56) CA2GABRA1GABRB2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387941-A1 Diphenyl-like Compound, Intermediate Thereof, Preparation Method Therefor, Pharmaceutical Composition Thereof And Uses Thereof SHANGHAI MAXINOVEL PHARMACEUTICALS CO., LTD. (CN) 2021-12-16 US disclosed
US-10246415-B2 Process for preparing carbazoles DOW GLOBAL TECHNOLOGIES LLC (US) 2019-04-02 US disclosed
WO-2018013067-A1 PROCESS FOR PREPARING CARBAZOLES DOW GLOBAL TECHNOLOGIES LLC (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10246415-B2 Process for preparing carbazoles DCLK2, DCLK1, PDCD2L CA2 1213/4885GABRA1 467/4885GABRB2 293/4885
US-20210387941-A1 Diphenyl-like Compound, Intermediate Thereof, Preparation Method Therefor, Pharmaceutical Composition Thereof And Uses Thereof CD274, PDCD1LG2, PDCD1 CA2 4758/4885GABRA1 2221/4885GABRB2 3514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.